Literature DB >> 13897160

New solid medium for enhanced growth of Pasteurella tularensis.

A J GASPAR, H B TRESSELT, M K WARD.   

Abstract

Gaspar, Andrew J. (Fort Detrick, Frederick, Md.), Hugh B. Tresselt, and Martha K. Ward. New solid medium for enhanced growth of Pasteurella tularensis. J. Bacteriol. 82:564-569. 1961.-The purpose of this work was to develop a solid medium for more rapid growth of Pasteurella tularensis, especially from small inocula comparable to those generally encountered in clinical materials. AFTER TITRATION OF VARIOUS INGREDIENTS, SEPARATELY AND IN COMBINATION, THE OPTIMAL BASE WAS FOUND TO BE: 2.6% tryptose broth (Difco) with thiamine, 0.5% cysteine-HCl, 0.2% sodium thioglycolate, 1.0% glucose, dissolved by mixing without heat, and adjusted to pH 7.2 +/- 0.03. To this base 1.0% agar (Difco) is added and dissolved by heating in flowing steam for about 5 min prior to autoclaving at 121 C for 20 min. After sterilization and cooling, 5.0% defibrinated rabbit blood is added aseptically. Plates of the completed medium are incubated at 37 C for 24 hr prior to use. Colonies of P. tularensis approximately 1.0 mm in diameter are obtained on this medium after 26 to 29 hr incubation if conditions of high relative humidity (90 to 100% saturation) are maintained.The mechanisms involved in the growth enhancement obtained on this medium are under study. The role of thioglycolate appears to be that of keeping in solution the relatively high concentration of cysteine-HCl required. The specific methods of preparation described, the incubation of plates prior to use, and final incubation under conditions of high humidity all are important for optimal results. This developmental work has employed only pure cultures. Attempts are being made to develop a selective medium, using this new preparation as base, for the direct isolation of P. tularensis from a variety of clinical materials.

Entities:  

Keywords:  PASTEURELLA TULARENSIS/culture

Mesh:

Substances:

Year:  1961        PMID: 13897160      PMCID: PMC279208          DOI: 10.1128/jb.82.4.564-569.1961

Source DB:  PubMed          Journal:  J Bacteriol        ISSN: 0021-9193            Impact factor:   3.490


  3 in total

1.  Studies on Pasteurella tularensis. I. Effect of duolite treatment on growth promoting properties of blood and plasma.

Authors:  A J GASPAR; M K WARD; H B TRESSELT
Journal:  J Lab Clin Med       Date:  1960-04

2.  Studies on the nutrition of Pasteurella tularensis.

Authors:  A TRAUB; J MAGER; N GROSSOWICZ
Journal:  J Bacteriol       Date:  1955-07       Impact factor: 3.490

3.  The Morphology of Bacterium tularense.

Authors:  W Hesselbrock; L Foshay
Journal:  J Bacteriol       Date:  1945-03       Impact factor: 3.490

  3 in total
  5 in total

1.  A transparent solid medium for growth enhancement of Pasteurella tularensis.

Authors:  A J GASPAR; J E FABER
Journal:  Appl Microbiol       Date:  1962-01

2.  Rapid comparative genomic analysis for clinical microbiology: the Francisella tularensis paradigm.

Authors:  Bernard La Scola; Khalid Elkarkouri; Wenjun Li; Tara Wahab; Ghislain Fournous; Jean-Marc Rolain; Silpak Biswas; Michel Drancourt; Catherine Robert; Stéphane Audic; Sven Löfdahl; Didier Raoult
Journal:  Genome Res       Date:  2008-04-11       Impact factor: 9.043

3.  Stimulation of human lymphocytes by a vaccine strain of Francisella tularensis.

Authors:  A Tärnvik; S Löfgren
Journal:  Infect Immun       Date:  1975-11       Impact factor: 3.441

4.  BLOOD-FREE MEDIUM FOR THE RAPID GROWTH OF PASTEURELLA TULARENSIS.

Authors:  H B TRESSELT; M K WARD
Journal:  Appl Microbiol       Date:  1964-11

5.  Francisella tularensis subspecies holarctica occurs in Swedish mosquitoes, persists through the developmental stages of laboratory-infected mosquitoes and is transmissible during blood feeding.

Authors:  J Thelaus; A Andersson; T Broman; S Bäckman; M Granberg; L Karlsson; K Kuoppa; E Larsson; E Lundmark; J O Lundström; P Mathisen; J Näslund; M Schäfer; T Wahab; M Forsman
Journal:  Microb Ecol       Date:  2013-09-21       Impact factor: 4.552

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.